Menu
Our Mission Sign Up

Tracking Myasthenia Gravis Symptoms

Tracking your symptoms is important when you live with myasthenia gravis. Get tips for tracking symptoms to help keep your healthcare team informed.

See If You Can Help Researchers by Sharing Your Myasthenia Gravis Journey
TRACKING SYMPTOMS

See If You Can Help Researchers by Sharing Your Myasthenia Gravis Journey

MyRealWorld® MG is an app-based research study, based on real-world evidence, designed to help advance the scientific understanding of myasthenia gravis.

3 MIN READ
Managing MG: There’s an App for That
TRACKING SYMPTOMS

Managing MG: There’s an App for That

Trying to manage myasthenia gravis is already a task in itself. One way that may help you stay organized could be used right from the palm of your hand.

4 MIN READ

YOU MAY ALSO LIKE

Learn More About Common Tools Neurologists Use to Chart Your Symptoms
DISEASE & TREATMENT

Learn More About Common Tools Neurologists Use to Chart Your Symptoms

Explore the worksheets that help doctors track your MG.

5 MIN READ
Been Living with MG for Some Time?
DISEASE & TREATMENT

Been Living with MG for Some Time?

Being prepared for changes in your MG can make a big difference.

5 MIN READ
The Importance of Setting Your Personal MG Treatment Goals
DISEASE & TREATMENT

The Importance of Setting Your Personal MG Treatment Goals

Having a goal helps you take small, realistic steps and track progress. Here’s how to set yours.

5 MIN READ

argenx, a global immunology company, created MG United to support people living with myasthenia gravis (MG) and those who care for them. By providing information on MG United, argenx aims to help improve the lives of people suffering from this autoimmune disease. MG United does not offer medical advice; always consult your healthcare team for personalized medical guidance.

The brands listed are the trademarks of their respective owners.

MG United by argenx

Intended for U.S. audiences only.     Privacy Policy | Contact Us | Disclaimer

©2023 argenx 

US-NON-22-00128 V1 10/2022

argenx